AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
5min chapter
Here are seven things Medtech VCs and start-up executives are thinking/worrying/excited about today
DeviceTalks Podcast Network
The Challenge on the Reimbursement Side Is in Part CMS and Other Payers, Too
Anali: I would agree, it continues to be the biggest risk factor. When we think about at what stage we can invest in a new technology on its path to the US market, we have to have reasonable timelines. Our funds are raised with 10-year lives to them. So ideally we're making new investments or new commitments to companies that come into the portfolio in years one through three. And if it takes 15 to 20 years to get from a new idea to an idea in the market that's got coding coverage payment and FDA approval, it doesn't make sense to invest in the first three rounds of a new medical device company.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode